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Introduction
Percutaneous transvenous mitral commissurotomy
(PTMC) is an effective and less invasive treatment
than surgical treatments for symptomatic mitral
stenosis.1–3 Left atrial body thrombus is considered to
be an absolute contraindication to the procedure due
to embolic risks. It has also been reported that inten-
sive warfarin therapy may lead to dissolution of left
atrial thrombus, after which successful PTMC can be
performed.4,5 In this report, we describe a patient with
rheumatic mitral stenosis who was referred for PTMC.
However, he was found to have a large, floating, left
atrial thrombus, occupying almost half of the left
atrial body as revealed by transthoracic echocardiog-
raphy and transesophageal echocardiography (TEE).
The patient strongly declined surgical mitral commis-
surotomy and left atrial thrombectomy treatment. He
was then referred back to the cardiologist at the local
hospital. After 2 years of warfarin therapy, complete
resolution of the left atrial thrombus was confirmed
by follow-up TEE. Successful PTMC was undertaken
without complications.
Case Report
A 41-year-old man with known rheumatic mitral steno-
sis was referred to our institution for PTMC because
of increasing dyspnea on exertion and orthopnea. He
had only recently been discharged from a local hospital
for pulmonary edema. Physical examination revealed
mild pulmonary rales at the bases, an opening snap,
and a diastolic rumbling murmur at the cardiac apex.
His electrocardiogram showed atrial fibrillation at
70beats/min. Transthoracic echocardiography was per-
formed and disclosed severe mitral stenosis with mild
mitral regurgitation and a large left atrial thrombus,
occupying almost half of the left atrial body (Figure 1A).
The calculated mitral valve area was 0.6cm2 with a mean
diastolic transmitral pressure gradient of 13 mmHg.
TEE demonstrated a large mobile left atrial throm-
bus, occupying almost half of the left atrial body, with
parts of the thrombus appearing fresh, protruding
and mobile (Figure 1B). There was severe sponta-
neous echo contrast in the left atrial body and a left
atrial appendage thrombus was present as well (Figure
1B). The mitral leaflets were moderately thickened
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and had restricted mobility, but there was no leaflet
calcification or distortion of the subvalvular structure.
The total mitral score was 5. Because the patient
strongly declined surgical mitral commissurotomy and
left atrial thrombectomy treatment, he was then referred
back to the cardiologist at a local hospital.
The patient was placed on warfarin therapy with a
dosage ranging between 1.25 mg and 3.75 mg per day
to maintain an international normalized ratio between
1.3 and 4.0 for the following 2 years. In the mean-
time, he was twice admitted for pulmonary edema at
the local hospital. His cardiac rhythm was intermit-
tently sinus with episodes of atrial fibrillation. He was
transferred back to our institution for recurrent pul-
monary edema and for a reassessment of his mitral
disease status 2 years after his first referral. A repeat
TEE was performed with no evidence of the left atrial
thrombus (Figure 1C). The cardiac rhythm was sinus,
and he was placed on amiodarone to prevent atrial
fibrillation. He underwent PTMC with a 26-mm Inoue
balloon up to 23-mm inflation (Figure 2A). The mitral
valve area increased from 0.6 cm2 to 1.85 cm2. The
mean transmitral pressure gradient decreased from 16
to 3 mmHg (Figure 2B) and pulmonary artery systolic
pressure declined from 91 to 52 mmHg (Figure 2C).
At subsequent follow-ups, the patient was symptom-
free and there was no evidence of emboli.
Discussion
Stroke is one of the most serious complications of
PTMC and is likely secondary to embolism from a left
atrial thrombus. The presence of left atrial thrombi is
a common finding in rheumatic mitral valve disease,
and the incidences reported in previous studies ranged
from 7.4% to 32%.4,5 Left atrial thrombus is considered
to be an absolute contraindication to the procedure
due to the risk of embolism.
Warfarin depletes the reduced form of vitamin K,
which is an important cofactor for post-translation
modification (carboxylation) of coagulation factors II,
VII, IX and X, thus inhibiting the coagulation path-
way.6–8 If coagulation is inhibited by warfarin and no
more thrombus is formed, gradual dissolution of the
thrombus by tissue-type plasminogen activator-related
fibrinolysis can be expected.
Some reports have shown that left atrial thrombi
may resolve in some patients after anticoagulant ther-
apy, and PTMC can be performed subsequently.4,5,9
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Figure 1. (A) Transthoracic echocardiography (parasternal long-axis
view) shows a large echogenic thrombus (arrow) in the left atrium,
occupying almost half of the left atrial body. (B) Transesophageal
echocardiography shows a large left atrial thrombus (arrowheads),
occupying almost half of the left atrial body. Parts of the thrombus
look mobile and fresh (arrow). (C) After 2 years of warfarin treat-
ment, complete resolution of the thrombus was confirmed by trans-
esophageal echocardiography. LA = left atrium; RA = right atrium;
AO = aortic orifice.
J Chin Med Assoc • December 2009 • Vol 72 • No 12648
W.C. Chang, et al
A report by Silaruks et al showed that of 219 PTMC
candidates with left atrial thrombus, complete resolu-
tion of the thrombus was demonstrated in 53 patients
(24.2%) after 6 months of warfarin treatment.4 In
another prospective study, Lin et al showed that the
resolution of left atrial thrombi was observed in 8 of
14 patients (57.2%) after warfarin therapy over a period
of 1–6 months.5 Only 1 patient obtained benefit from
longer warfarin therapy (>6 months), while in the other
7 patients, thrombus resolution occurred within 3
months.5 Therefore, it is not wise to delay PTMC for
an extended period to wait for complete thrombus
resolution, because stroke and refractory heart failure
might occur during the interval. In our case, because
the patient strongly declined surgical treatment, he
was placed on warfarin treatment for 2 years and
monitored periodically at a local hospital. Complete
resolution of left atrial thrombus was proved by TEE
2 years later.
Lin et al reported that the resolution of left atrial
thrombi was more frequently observed in patients
either with a smaller left atrial dimension or with their
thrombi located inside their left atrial appendage.5 An
analysis by Silaruks et al4 showed that the significant
predictors of thrombus resolution were a New York
Heart Association class of 2 or less, a left atrial ap-
pendage thrombus size of 1.6 cm2 or less, a left atrial
spontaneous echocardiographic contrast grade of 1 or
B
50
1000 ms 1000 ms
45
40
35
30
25
20
15
10
5
0
50
45
40
35
30
25
20
15
10
5
0
LV
Baseline A BPost-PTMC
LA
A
100
90
80
70
60
50
40
30
20
10
0 Baseline
50
53
7
45
30
2828
4645
40
35
30
25
20
15
10
5
0 Post-PTMC
C
Figure 2. (A) An Inoue balloon was inflated during percutaneous transvenous mitral commissurotomy. (B) Mean transmitral pressure
gradient decreased from 16 to 3 mmHg after percutaneous transvenous mitral commissurotomy (left panel: baseline; right panel: 
post-percutaneous transvenous mitral commissurotomy [PTMC]). (C) Pulmonary artery systolic pressure declined from 91 to 52 mmHg
after PTMC (left panel: baseline, top scale bar 100 mmHg; right panel: post-PTMC, top scale bar 50 mmHg).
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less, and an international normalized ratio of at least
2.5. Patients with all of these predictors had a 94.4%
chance of complete thrombus resolution. Our case had
several unfavorable characteristics for predicting the
thrombus resolution, including a large baseline left atrial
size of 5.9 cm, a large thrombus occupying almost half
of the left atrial body, a New York Heart Association
class 3–4 symptom, and an erratic international normal-
ized ratio range.
In conclusion, left atrial thrombi can be resolved
completely after optimal anticoagulation in a consid-
erable proportion of patients with rheumatic mitral
stenosis. Subsequent PTMC can be performed safely
without an increased risk of systemic embolization.
Left atrial thrombus should not be an absolute con-
traindication for PTMC. However, we believe surgery
should be the first-line therapy for patients with large
mobile left atrial thrombus. Furthermore, we do not re-
commend such a long waiting period because there is
a potential risk of cardiac emboli during the follow-up
interval.
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